Precision for Medicine Acquires ACT Oncology         

Committed Advocates

ACT Oncology is an active member of the BioNJ (, an organization advancing biotechnology and biotechnology-related industries in New Jersey. Our staff members regularly attend ASCO, ASH and ESMO annual meetings, related industry conferences and therapeutic-area training sessions.  Check our “Recent News” to see where ACT Oncology will be speaking or exhibiting next.

We're changing our name and website to reflect our exciting new capabilities since joining Precision for Medicine. Please visit us at to see how we’re delivering the next generation of CRO services for oncology innovators.